X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/09/2859935/0/en/Aligos-Therapeutics-to-Participate-in-the-Piper-Sandler-Spring-Biopharma-Symposium-2024.html
https://www.globenewswire.com/news-release/2024/04/03/2856887/0/en/Aligos-Therapeutics-Announces-First-Subjects-Dosed-in-the-Phase-2a-HERALD-Study-of-ALG-055009-in-MASH-Subjects.html
https://www.globenewswire.com/news-release/2024/03/27/2853096/0/en/Aligos-Therapeutics-Presents-Positive-Clinical-Data-at-APASL-2024-from-ALG-055009-and-ALG-000184-Phase-1-Studies.html
https://www.globenewswire.com/news-release/2024/03/18/2847754/0/en/Aligos-Therapeutics-Announces-the-Initiation-of-the-Phase-2a-HERALD-Study-of-ALG-055009-in-MASH-Subjects.html
https://www.globenewswire.com//news-release/2024/03/12/2845001/0/en/Aligos-Therapeutics-Reports-Recent-Business-Progress-and-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/05/2840889/0/en/Aligos-Therapeutics-to-Announce-4th-Quarter-2023-Financial-Results-on-March-12-2024.html
https://www.globenewswire.com//news-release/2024/02/26/2835063/0/en/Aligos-Therapeutics-To-Participate-in-the-Leerink-Partners-Global-Biopharma-Conference-2024.html
https://www.globenewswire.com//news-release/2024/02/20/2831758/0/en/Aligos-Therapeutics-to-Host-KOL-Event-to-Discuss-Phase-2a-HERALD-Study-of-ALG-055009-in-MASH-on-March-7-2024.html
https://www.globenewswire.com//news-release/2024/02/13/2828204/0/en/Aligos-Therapeutics-Strengthens-Finance-Leadership-Team-with-Two-New-Appointments.html
https://www.globenewswire.com//news-release/2023/12/07/2792888/0/en/Transactions-in-Zealand-Pharma-shares-and-or-related-securities-by-persons-discharging-managerial-responsibilities-and-or-their-closely-associated-persons.html
Market Place
Share 
